Citadel Advisors
SHC icon

Citadel Advisors’s Sotera Health SHC Stock Holding History

Citadel Advisors’s Portfolio SHC Stock Details SHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,800
Closed -$332K – 14101
2025
Q4 		$332K Sell
18,800
-700
-4% -$11.6K ﹤0.01% 9922
2025
Q3 		$307K Buy
+19,500
New +$274K ﹤0.01% 10321
2025
Q2 		– Sell
-300
Closed -$3.5K – 14811
2025
Q1 		$3.5K Sell
300
-6,400
-96% -$82.4K ﹤0.01% 13960
2024
Q4 		$91.7K Sell
6,700
-3,600
-35% -$52.2K ﹤0.01% 11608
2024
Q3 		$172K Sell
10,300
-500
-5% -$7.3K ﹤0.01% 10371
2024
Q2 		$128K Sell
10,800
-5,200
-33% -$59.4K ﹤0.01% 10562
2024
Q1 		$192K Buy
16,000
+9,600
+150% +$143K ﹤0.01% 10382
2023
Q4 		$108K Buy
6,400
+1,500
+31% +$21.2K ﹤0.01% 10836
2023
Q3 		$73.4K Sell
4,900
-6,300
-56% -$106K ﹤0.01% 11272
2023
Q2 		$211K Sell
11,200
-22,600
-67% -$359K ﹤0.01% 9761
2023
Q1 		$605K Buy
33,800
+30,500
+924% +$510K ﹤0.01% 7925
2022
Q4 		$27.5K Sell
3,300
-9,500
-74% -$70.9K ﹤0.01% 12839
2022
Q3 		$87K Buy
+12,800
New +$213K ﹤0.01% 11211
2021
Q4 		– Sell
-7,800
Closed -$204K – 14666
2021
Q3 		$204K Buy
+7,800
New +$189K ﹤0.01% 11950

Other funds holding SHC

DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return
GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors's SHC Position: Q1 2026 in Review

Citadel Advisors increased its Sotera Health (SHC) stake by 14% in Q1 2026, buying an estimated $1.44M and bringing the position to 691,387 shares worth $9.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3270.

Citadel Advisors first reported a position in SHC in Q4 2020 and has held it in 19 quarters since. The position peaked at $94.9M in Q1 2023. 296 funds tracked by Wall St. Rank hold SHC as of Q1 2026.

  • Citadel Advisors held 691,387 shares of Sotera Health worth $9.91M as of Q1 2026.
  • Citadel Advisors bought 86,543 Sotera Health shares in Q1 2026, an estimated $1.44M.
  • Sotera Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3270 holding.
  • Citadel Advisors first reported a position in Sotera Health in Q4 2020 and has held it in 19 quarters since.
  • Citadel Advisors's Sotera Health position peaked at $94.9M in Q1 2023.
  • 296 funds tracked by Wall St. Rank held Sotera Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.